Journal of Diabetes and Its Complications
Volume 16, Issue 5 , Pages 352-358 , September 2002

Elevated serum KL-6 concentrations in patients with diabetes mellitus

  • Toru Takahashi

      Affiliations

    • First Department of Medicine, School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo, Japan
    • First Department of Biochemistry, School of Medicine, Sapporo Medical University, S-1, W-7, Chuo-ku, Sapporo 060-8556, Japan
    • Corresponding Author InformationCorresponding author. First Department of Biochemistry, School of Medicine, Sapporo Medical University, S-1, W-7, Chuo-ku, Sapporo 060-8556, Japan. Tel.: +81-11-611-2111x2673; fax: +81-11-611-2236
    • ,
  • Kei Takamura

      Affiliations

    • First Department of Medicine, School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo, Japan
    • ,
  • Sinji Sakaue

      Affiliations

    • First Department of Medicine, School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo, Japan
    • ,
  • Jun Ishii

      Affiliations

    • Department of Internal Medicine, Hokkaido Central Hospital for Social Health Insurance, 1-8-3-18, Nakanoshima, Toyohira-ku, Sapporo, Japan
    • ,
  • Hiroshi Yokouchi

      Affiliations

    • First Department of Medicine, School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo, Japan
    • ,
  • Yasuyuki Nasuhara

      Affiliations

    • First Department of Medicine, School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo, Japan

Received 30 June 2001 ,Revised 23 October 2001 ,Accepted 31 October 2001.

References 

  1. Aoki Y, Yanagisawa Y, Ohfusa H, Kawa S, Oguchi H, Furuta S. Elevation of serum CA 19-9 in parallel with HbA1c in a diabetic female with the Lewis (a+,b−) blood group. Diabetes Research and Clinical Practice. 1991;13:77–81
  2. Banfi G, Ardemagni A, Bravi S, Pacchioni M, Bonini P. Are diabetic metabolic compensation and CA 19.9 really correlated?. International Journal of Biological Markers. 1996;11:207–210
  3. Bjorn SF, Bangstad HJ, Hanssen KF, Nyberg G, Walker JD, Viberti GC, et al. Glomerular epithelial foot processes and filtration slits in IDDM patients. Diabetologia. 1995;38:1197–1204
  4. Ellis EN, Steffes MW, Chavers B, Mauer SM. Observations of glomerular epithelial cell structure in patients with type I diabetes mellitus. Kidney International. 1987;32:736–741
  5. Hermans C, Bernard A. Lung epithelium-specific proteins. American Journal of Respiratory Critical Care Medicine. 1999;159:646–678
  6. Johnson MA, Kwan S, Snell NJ, Nunn AJ, Darbyshire JH, Turner-Warwick M. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose of prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax. 1989;44:280–288
  7. King GL, Banskota NK. Mechanisms of diabetic microvascular complications. In:  Weir CR,  Kahn GC editor. Joslin's diabetes mellitus. Baltimore: Williams & Wilkins; 1994;p. 631–647
  8. King TE. Idiopathic pulmonary fibrosis. In:  Schwarz MI,  King TE editor. Interstitial lung disease. Ontario: Decker; 1998;p. 597–644
  9. Kobayashi J, Kitamura S. KL-6: a serum marker for interstitial pneumonia. Chest. 1995;108:311–315
  10. Kobasyashi J, Kitamura S. Serum KL-6 for the estimation of active pneumonitis in pulmonary sarcoidosis. Chest. 1996;109:1276–1282
  11. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Japan Journal of Clinical Oncology. 1988;18:203–216
  12. Kohno N, Awaya Y, Oyama T, Yamakido M, Akiyama M, Inoue Y, et al. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. American Review of Respiratory Disease. 1993;148:637–642
  13. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Chest. 1989;96:68–73
  14. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, et al. Report of the Committee of Japan Diabetic Society on the Classification and Diagnostic Criteria of Diabetes Mellitus. Journal of Japan Diabetic Society. 1999;42:385–404
  15. Magnani JL, Brockhaus M, Smith DF, Ginsburg V, Blaszczyk M, Mitchell KF, et al. A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science. 1981;212:55–56
  16. Magnani JL, Nilsson B, Brockaus M, Zopf D, Steplewski Z, Koprowski H, et al. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. Journal of Biological Chemistry. 1982;257:14365–14369
  17. Magnani JL, Steplewski Z, Koprowski H, Ginsburg V. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Research. 1983;43:5489–5492
  18. Nakamura N, Aoji O, Yoshikawa T, Mori K, Kajiyama S, Kitagawa Y, et al. Elevated serum CA 19-9 levels in poorly controlled diabetic patients. Japanese Journal of Medicine. 1986;25:278–280
  19. Ortiz A, Ziyadeh FN, Neilson EG. Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. Journal of Investigative Medicine. 1997;45:50–56
  20. Petit JM, Vaillant G, Olsson NO, Guignier F, Collignon S, Verges B, et al. Elevated serum CA 19-9 levels in poorly controlled diabetic patients—relationship with Lewis blood group. Gastroenterologie Clinique et Biologique. 1994;18:17–20
  21. Shimojo N, Naka K, Nakajima C, Ishizaki T, Okuda K, Murai J, et al. The effect of non-insulin-dependent diabetes on serum concentrations of tumor-associated carbohydrate antigens of CA19-9, CA50, and sialyl SSEA-1 in association with the Lewis blood phenotype. Clinica Chimica Acta. 1990;190:283–290
  22. Takahashi T, Munakata M, Ohtsuka Y, Satoh-Kamachi A, Sato R, Homma Y, et al. Serum KL-6 concentrations in dairy farmers. Chest. 2000;118:445–450
  23. Takahashi T, Munakata M, Suzuki I, Kawakami Y. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis. American Journal of Respiratory Critical Care Medicine. 1998;158:1294–1298
  24. Unger RH, Foster DW. Diabetes mellitus. In:  Wilson JD,  Foster DW,  Kronenberg HM,  Larsen PR editor. Williams textbook of endocrinology. Philadelphia: W.B. Saunders; 1998;p. 973–1059
  25. Viberti GC, Mackintosh D, Keen H. Determinants of the penetration of proteins through the glomerular barrier in insulin-dependent diabetes mellitus. Diabetes. 1983;32(Suppl. 2):92–95
  26. Vracko R, Thorning D, Huang TW. Basal lamina of alveolar epithelium and capillaries: quantitative changes with aging and in diabetes mellitus. American Review of Respiratory Disease. 1979;120:973–983
  27. Wiseman MJ, Viberti GC, Keen H. Threshold effect of plasma glucose in the glomerular hyperfiltration of diabetes. Nephron. 1984;38:257–260
  28. Yokoyama A, Kohno N, Kondo K, Ueda S, Hirasawa Y, Watanabe K, et al. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA 19-9 and SLX as serum markers for interstitial pneumonia. Respirology. 1998;3:199–202
  29. Yoshioka K. Elevation and fluctuation of serum CA 19-9 and SPAN-1 levels after administration of sulfonylurea in diabetic with Lewis (a−,b−) blood phenotype. Diabetes Care. 1995;18:1397–1399

PII: S1056-8727(01)00220-3

Journal of Diabetes and Its Complications
Volume 16, Issue 5 , Pages 352-358 , September 2002

Article Tools

* Image Usage & Resolution